Tretinoin/benzoyl peroxide explained
Type: | combo |
Component1: | Tretinoin |
Class1: | Retinoid |
Component2: | Benzoyl peroxide |
Class2: | Oxidizing agent |
Tradename: | Twyneo |
Dailymedid: | Tretinoin_and_benzoyl_peroxide |
Routes Of Administration: | Topical |
Atc Prefix: | D10 |
Atc Suffix: | AD51 |
Legal Us: | Rx-only |
Legal Us Comment: | [1] |
Kegg: | D12338 |
Synonyms: | S6G5T-3 |
Tretinoin/benzoyl peroxide, sold under the brand name Twyneo, is a fixed-dose combination medication used for the treatment of acne. It contains tretinoin, a vitamin A derivative, and benzoyl peroxide, an oxidizing agent.[2]
The combination was approved for medical use in the United States in July 2021.[3] [4] [5]
External links
- Web site: Tretinoin . U.S. National Library of Medicine . Drug Information Portal .
- Web site: Benzoyl peroxide . U.S. National Library of Medicine . Drug Information Portal .
Notes and References
- Web site: Twyneo (tretinoin and benzoyl peroxide) cream, for topical use . U.S. Food and Drug Administration .
- Ochsendorf F . Clindamycin phosphate 1.2% / tretinoin 0.025%: a novel fixed-dose combination treatment for acne vulgaris . Journal of the European Academy of Dermatology and Venereology . 29 . Suppl 5. 8–13 . June 2015 . 26059820 . 10.1111/jdv.13185 . 29681121 . free .
- Sol-Gel Technologies Announces FDA Approval of Twyneo . Sol-Gel Technologies Ltd. . GlobeNewswire . 27 July 2021 . 27 July 2021.
- Web site: Twyneo: FDA-Approved Drugs . U.S. Food and Drug Administration (FDA) . 27 July 2021.
- Web site: NDA Approval: Twyneo . 26 July 2021 . U.S. Food and Drug Administration .